HCV Coinfection Completed Phase 2 Trials for Boceprevir (DB08873)

Also known as: Hepatitis (non-A non-B) / Viral hepatitis C / Hepatitis non-A non-B / Non-A non-B hepatitis / Hepatitis C / Unspecified viral hepatitis C / Hep non-A non-B

IndicationStatusPhase
DBCOND0048683 (HCV Coinfection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01335529Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/RibavirinTreatment